Go Back

Bio Weekly: S2 Ignition, Brain Health Trial, AI Scientist Micropayments, DeSci Playbook

DeSci
Tech
Contents

Highlights from the Biosphere 🌐

Payment Rails for AI Scientists

BioAgents can now pay for data and services on their own by using @CoinbaseDev's x402 + Embedded Wallets for instant USDC micropayments on @base. This allows Bio's network of Scientific AI Agents to coordinate across different research domains and offer services to third-parties: human-to-agent, agent-to-agent and agent-to-lab.

BioAgents are “agentic science machines” - continuous AI-driven workers designed to execute tasks in the R&D lifecycle, such as reading literature, hypothesis generation, and designing experiments. They are trained on custom datasets curated by researchers and distributed research communities.

The first BioAgent, @Aubrai_, a longevity AI scientist co-developed in partnership with @vitadao and the renowned longevity researcher Dr. @aubreydegrey, became the first x402-powered BioAgent, enabling Aubrai to receive and issue payments.

The integration unlocks a number of potential use-cases, such as:

  • Hypothesis & Knowledge Graph Refinement: Agents compensate researchers who provide hypothesis feedback or improve agent intelligence by uploading new data, papers and findings to an agent's knowledge graph.
  • Agent-to-Agent Collaboration: Agents exchange computational insights - eg., Agent A (Genomics Specialist) sells preprocessed embeddings, Agent B (Drug Designer) pays via x402 when retrieving cluster signatures.
  • Pay-Per-Analysis: Agents expose computational pipelines as on-demand services.
  • Pap-Per-Data Access: Agents host premium or proprietary datasets with fine-grained micro-billing per retrieval request.

➤ Watch Coinbase GTM lead @The_Shark_7 demo the integration in this video.

➤ Build on the new x402-compatible BioAgent framework or test Aubrai payments on x402scan.

➤ Learn more about x402 & BioAgents ↓

Bio S2 Launch Mechanics & Upcoming Launches

We hosted a Bio Open Lab Spaces diving into the recently announced details on Bio Launchpad Season 2 and the next projects to launch.

Highlights ↓

➤ First S2 Ignition Sales

➤ S2 Launch Mechanics

  • Sales switch to USDC for cleaner routing, permissionless launches & less risk to BIO holders
  • As project FDV clears tiers and holds ≈2 weeks, USDC is unlocked for research funding
  • Winners later get a BIO pair; weaker experiments don’t drag BIO price

➤ Staking, XP & Airdrops

  • Stake BIO → earn BioXP → use BioXP + USDC to access sales
  • Ecosystem airdrops to BIO stakers
  • BIO stakers earn Multipliers that boost BioXP rewards for staking new ecosystem tokens in their first 60 days.

➤ Launchpad & Liquidity

  • Integration with @AerodromeFi on Base; pool launcher used from day one
  • Eligible tokens get Coinbase DEX Trading visibility at launch
  • BNB bridge for BIO approved by governance & launchpad coming to BNB

➤ Listen to the Bio Open Lab covering S2 Mechanics, as well as live interviews with the founders of DROPS & GALE, launching soon on Bio.

Workshop: How to Fundraise with Bio

With the upcoming launch of Season 2, we hosted a livestream exploring how to use Bio to fund and accelerate scientific research, featuring Bio's Chief Science Officer,

@jamessinka, & Curetopia founder, @eperlste.

Apply now to fund your research on Bio

➤ Watch the workshop recording to learn more about the evolving DeSci Playbook ↓

Ecosystem Updates

  • Cerebrum DAO's Percepta project's clinical trial infrastructure is complete, with the first tokenized brain health supplement reaching double-blind placebo-controlled human trials soon. They also shared more about the research behind their upcoming IPT, NEURON-GALE, launching on Bio soon.
  • VitaDAO announced S2 of VitaLabs, prioritizing projects using @aubrai_ for hypothesis generation, experiment design, and science development - apply here. The lead researcher of VITARNA won the Best New Drug Developer at this year's World ADC & they hosted a community call covering VitaLabs S1 outcomes, @Aubrai_ IPT updates, PortCos progress & more. Vita also opened up 3 job openings across AI Engineering, Growth & Operations.
  • HairDAO have spent $260K testing 60+ dutasteride delivery vehicles & released their precision dutasteride, based on their lessons. Learn more about their formulation & order here.
  • Curetopia shared the initial mouse study results on their $RAPTOR intervention within less than 3 months since token launch. The results showed that a low-dose enhanced grip strength and endurance via balanced autophagy modulation, while a higher dose triggered hypothermia and immune stress.
  • Quantum Biology DAO hosted the first ever quantum biology hackathon, with 29 contributors coming together to develop 6 different projects exploring how quantum effects might influence living systems.
  • Pump Science started the next worm experiments with DOCS becoming the new king of the pill, achieving a 80% lifespan extension. The first chemical reprogramming intervention was also launched on Pump Science by the Reprogramming Lab & the Rapamycin Longevity Lab.
  • D1ckDAO partnered with Episteme to launch their first prediction market, powered by a @D1ckGPT hypothesis, testing whether daily Panax Ginseng can improve erectile function on par with 5mg tadalafil (Cialis) & did a live demo of D1ckGPT at Thailand Blockchain Week.
  • MicroDAO shared their Q3 update, highlighting their Pathogen Catalogue, delivering key pathogen metrics and data, launching by year-end, their Collective Research Platform, guiding researchers end-to-end, entering closed alpha in early 2026, and their Economic Impact Calculator, modeling fiscal effects of pathogen interventions, reaching alpha testing in early 2026.
  • SpineDAO presented their AI suite at the SOFCOT CAOS event in Paris.

Community Updates

Explore New DeSci projects on the Bio App.

Stay updated via our Telegram, Discord, Governance forum. Follow @BioProtocolEco on X for real-time ecosystem updates.

https://www.bio.xyz/blog-posts/bio-weekly-s2-ignition-brain-health-trial-ai-scientist-micropayments-desci-playbook